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RORgt, a Novel Isoform of an Orphan Receptor,
Negatively Regulates Fas Ligand Expression
and IL-2 Production in T Cells
et al., 1995; Sytwu et al., 1996). Defects in this pathway
result in autoimmune diseases that are best exemplified
by the lymphoproliferative and autoimmune phenotype
in lpr and gld mice and autoimmune lymphoproliferative
syndrome (ALPS) in humans (Nagata and Goldstein,
You-Wen He, Michael L. Deftos,
Ethan W. Ojala, and Michael J. Bevan*
Department of Immunology
and Howard Hughes Medical Institute
University of Washington
Seattle, Washington 98195 1995; Puck and Sneller, 1997).
The molecular mechanism of TCR-mediated cell death
has been deduced mainly from studies on T cell hybrido-
mas. TCR-mediated activation of T cell hybridomasSummary
leads to IL-2 production and upregulation of Fas and Fas
ligand. The engagement of Fas by Fas ligand initiates theWe have identified RORgt, a novel, thymus-specific
death program (Alderson et al., 1995; Brunner et al.,isoform of the orphan nuclear receptor RORg that is
1995; Dhein et al., 1995; Ju et al., 1995). Several genesexpressed predominantly in CD41 CD81 double-posi-
have been identified as regulators of Fas/Fas ligandtive thymocytes. Ectopic expression of RORgt pro-
death pathway such as c-myc (Hueber et al., 1997),tects T cell hybridomas from activation-induced cell
TDAG51 (Park et al., 1996), ALG-2, ALG-3 (Vito et al.,death by inhibiting the upregulation of Fas ligand. Fol-
1996), GILZ (D'Adamio et al., 1997), and Toso (Hitoshilowing hybridoma stimulation, RORgt also inhibits IL-2
et al., 1998).production but does not affect the induction of Nur-
The nuclear hormone receptor superfamily is com-77 and Egr-3 nor the upregulation of CD69. Both the
posed of ligand-regulated transcription factors and or-ligand-binding and DNA-binding domains of RORgt
phan receptors, for which ligands are not identified orare required for this effect. We propose that the role
may not exist (Beato et al., 1995; Mangelsdorf and Ev-of RORgt expression in immature thymocytes is to
ans, 1995; Laudet, 1997). These receptors perform ex-inhibit Fas ligand expression and cytokine secretion
tremely diverse functions in development, reproduction,following engagement of their TCR during positive or
and homeostasis by regulating cell growth, differentia-negative selection.
tion, and apoptosis (Kastner et al., 1995). Various hor-
mones and their receptors have been shown to modu-Introduction
late a broad spectrum of immunological processes.
Retinoids are important cofactors in T cell activationOnly a small fraction of thymocytes meet certain selec-
(Garbe et al., 1992). Vitamin D3 inhibits proliferation andtion criteria to mature and become peripheral CD41 or
immunoglobulin production in B cells (Provvedini et al.,CD81 single-positive (SP) lymphocytes. Immature dou-
1984). Both retinoic acid and glucocorticoids antagonizeble-positive (DP) thymocytes expressing a TCR with in-
TCR-mediated cell death by inhibiting activation-inducedtermediate affinity for self-MHC-peptide complexes are
Fas ligand upregulation (Yang et al., 1995). Nur-77, anpositively selected and complete maturation. Immature
orphan nuclear receptor, is required for TCR-inducedDP thymocytes that express TCR with too-low affinity
apoptosis of T cell hybridomas (Liu et al., 1994; Woroniczundergo programmed cell death, referred to as ªdeath
et al., 1994). In transgenic thymocytes that overexpressby neglect,º while thymocytes expressing TCR with too-
Nur-77, Fas ligand mRNA expression was stronglyhigh affinity for self-MHC-peptide ligand are also deleted
upregulated (Weih et al., 1996), whereas a dominant-by programmed cell death, which is referred to as nega-
negative form of Nur-77 expressed in the thymus inter-tive selection (Kisielow and von Boehmer, 1995; Jame-
feres with thymocyte negative selection, presumably byson and Bevan, 1998). Although the mechanism by
inhibiting the action of Nur-77 and the related orphanwhich signaling through a high-affinity TCR results in
receptor Nor-1 (Calnan et al., 1995; Zhou et al., 1996).negative selection of thymocytes is unclear, certain
pairs of cell surface molecules including CD40/gp39 and These studies suggest that a complex network involving
CD30/CD30 ligand have been implicated in thymocyte multiple regulators controls the Fas/Fas ligand death
negative selection (Foy et al., 1995; Amakawa et al., program.
1996). With one exception (Castro et al., 1996), Fas/Fas To further explore the molecular mechanism that un-
ligand interaction has not been shown to be involved in derlies TCR-mediated cell death, we have employed
immature DP negative selection in vivo. A recent study an expression cloning strategy to identify genes that
demonstrates that Fas-mediated clonal deletion of self- regulate this pathway. Here, we report the isolation of
reactive T cells in the thymus occurs at a relatively late RORgt, a novel isoform of the orphan nuclear receptor
stage of thymocyte development at the ªsemimatureº RORg (retinoic acid receptor-related orphan receptor)
SP stage and is dependent on the dose of the antigen (Hirose et al., 1994; Ortiz et al., 1995), that is expressed
(Kishimoto et al., 1998). The interaction of Fas and Fas primarily in immature DP thymocytes. Expression of
ligand also plays an important role in TCR-induced ma- RORgt protects T cell hybridomas from activation-induced
ture T cell apoptosis in the lymphoid periphery (Zheng cell death by inhibiting the upregulation of Fas ligand.
RORgt also inhibits IL-2 production but does not affect
the induction of Nur-77 and Egr-3 nor the upregulation* To whom correspondence should be addressed (e-mail: mbevan@
u.washington.edu). of CD69 upon T cell activation. We propose that RORgt
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expression in DP immature thymocytes inhibits Fas li-
gand expression and cytokine secretion following en-
gagement of their TCR during positive or negative se-
lection.
Results
Cloning of RORgt
We used an expression cloning strategy to identify
genes that are involved in TCR/CD3-mediated apopto-
sis. DO11.10 T cell hybridoma cells were infected with
a thymocyte cDNA library cloned in a retroviral vector
and selected for growth in the presence of phorbol my-
ristate acetate (PMA) plus ionomycin, which induce the T
cell hybridoma to undergo activation-induced apoptosis
by direct activation of protein kinase C and elevation of
Ca11. cDNA inserts from resistant clones were recloned
and transduced into DO11.10 cells to confirm their anti-
apoptotic effects. One 2.0 kb cDNA insert that con-
ferred resistance to PMA plus ionomycin and to anti-
CD3-induced cell death in DO11.10 cells was further
investigated in this work.
Sequence analysis of this cDNA revealed that it en-
codes an open reading frame of 495 amino acids (Figure
1A). The nucleotide sequence from nt 101 through the 39
untranslated region is identical to RORg/TOR, an orphan
nuclear receptor with unknown function that was cloned
independently from skeletal muscle and EL4 T cell librar-
ies (Hirose et al., 1994; Ortiz et al., 1995; Medvedev et
al., 1996). The matched sequence corresponds to exon
3 to exon 11 of RORg (Medvedev et al., 1997). It has the
same DNA-binding domain (DBD) and ligand-binding
domain (LBD) as RORg. The novel cDNA sequence dif-
fers from that of RORg only in the first 100 nucleotides,
which translate into distinct N-terminal amino acid se-
quences (Figure 1B). Therefore, this cDNA insert from
the thymocyte library represents a new isoform of RORg.
The putative initiation codon begins at nt 93 and is sur-
rounded by a standard Kozak consensus sequence. An
in-frame termination codon lies 27 nt upstream of the
putative initiation codon (Figure 1). Since it is primarily
expressed in the thymus (see below), this novel isoform
of RORg was designated RORgt.
Expression of RORgt
Previous studies demonstrated that RORg is expressed
in a variety of tissues, including thymus and skeletal
muscle (Ortiz et al., 1995; Medvedev et al., 1996). How-
ever, these studies did not discriminate the expression
of RORgt and RORg. To investigate the tissue distri- Figure 1. RORgt Is a Novel Isoform of RORg
bution of the two isoforms, we designed primers that (A) cDNA sequence of RORgt and its predicted amino acid se-
are common to both or specific for one of the isoforms quence. The cDNA sequence of RORgt was derived from sequenc-
ing the rescued cDNA insert from DO11.10 clones that were resistantand examined their mRNA expression by reverse tran-
to PMA plus ionomycin-induced cell death. Several independentscriptase polymerase chain reaction (RT-PCR) (Figure
RT-PCR from thymocyte RNA yielded the same sequence. Sequences2A). The RT-PCR products were then blotted and probed
for the DBD (aa 10±75) and LBD (aa 305±460) are underlined. The
with a full-length RORgt cDNA. 39 untranslated region is identical to that of RORg (Medvedev et al.,
Among all the tissues examined, the RORgt isoform 1997) and is not included.
was detected solely in the thymus (Figure 2B). In con- (B) Sequence comparison of RORgt and RORg. Aligned are the first
114 nt and the predicted amino acid sequence for RORgt and RORg.trast, RORg was detected in the thymus, muscle, brain,
They share the same sequence beginning with the underlined nucle-heart, kidney, liver, and lung with strong signals in mus-
otides through the 39 end of each cDNA.cle, kidney, and liver. Interestingly, neither isoform was
found in the spleen or bone marrow, indicating that
mature T cells, as well as B cells at different stages of
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Figure 2. Differential Expression of RORgt and RORg
(A) Schematic representation of RORgt and RORg cDNAs and the
locations of the primers used in (B) and (C). The shaded region
represents the distinct nucleotide sequences. Specific primers are
1 and 2. Common primers are 3, 4, and 5. Diagram is not to scale.
(B) Expression of RORgt and RORg. RT-PCR products of different
tissues were blotted and probed with a full-length RORgt cDNA.
HPRT serves as an internal control. Numbers in parentheses indicate
the primers shown in (A) used in the PCR.
(C) Expression of RORgt in thymocyte subpopulations. RT reactions
of different thymocyte subpopulations were serially diluted at 1:3
and subjected to PCR with primers shown in (A). PCR products
were blotted and probed as in (B). HPRT RT-PCR was performed
from the same RT samples for cDNA template quantity control.
their development, do not express this nuclear receptor.
Consistent with the expression pattern of RORgt and
RORg, a primer set common for both isoforms amplified
Figure 3. Expression of RORgt Protects T Cell Hybridomas fromsignals from the above tissues shown to be positive
Activation-Induced Cell Death
for either isoform (Figure 2B). A weak signal was also
(A) Vector control cells and DO11.10 or KMIs-8.3.5 clones express-detected in the spleen by the common primer set. This
ing RORgt were cultured in either 2C11-coated plates or in PMA (10
signal may represent a third isoform of RORg (Figure 2B). ng/ml) plus various amounts of ionomycin and measured for their
The expression of RORgt in thymocyte subpopulations [3H]Thymidine incorporation. The [3H]Thymidine uptake of individual
was further examined in fluorescence-activated cell cell lines cultured in medium alone is calculated as 100%. Shown
are the results from two individual hybridoma clones expressingsorting (FACS)-sorted immature DN and DP and mature
RORgt (circles) or control cells (squares).CD41 and CD81 SP thymocytes. RORgt is predomi-
(B) KMIs-8.3.5 vector control cells and a clone expressing RORgtnantly expressed in immature DP thymocytes, with a low
were cultured in PMA (10 ng/ml) plus ionomycin (0.2 mg/ml) for 16
expression level in DN thymocytes and no detectable hr. Apoptotic cells with subdiploid DNA content were determined
expression in either CD41 or CD81 SP thymocytes under by propidium iodide uptake, and the percentage is indicated.
these conditions (Figure 2C). In addition, RORgt is not
expressed by the T cell hybridomas DO11.10 and KMIs-
cloned into this vector is transcribed into bicistronic8.3.5 and is not induced upon activation of these cells
mRNA that concomitantly directs translation of the in-either by anti-CD3 MAb or PMA plus ionomycin treat-
sert and hCD2. Retrovirus-infected, transgene-positivement (data not shown). These data indicate that the
polyclonal or monoclonal cell lines were established byexpression of RORgt is tightly regulated in the thymus
either FACS or multiple rounds of panning for hCD2 posi-and suggest a role for RORgt in thymocyte development.
tive cells. A pMX-hCD2 construct was used as a control
vector and hCD2 positive hybridoma cells were isolatedRORgt Protects Hybridomas from
as control cells. Apoptosis induced by anti-CD3 MAbTCR/CD3-Mediated Cell Death
or PMA plus ionomycin was measured by comparingTo study the function of RORgt, full-length RORgt cDNA
[3H]Thymidine uptake of these cells in the absence orwas transduced into hybridoma cells using a pMI retrovi-
presence of these stimuli (Figure 3A). The [3H]Thymidinerus vector. The pMI vector contains an IRES-hCD2 re-
porter construct downstream of the cDNA insert. cDNA incorporation by these cells closely correlated with their
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Figure 4. Protection of T Hybridomas from
Activation-Induced Apopotosis by RORgt
Deletion Mutants or RORg
(A) Both the DBD and the LBD of RORgt are
required to protect T cell hybridomas from
activation-induced cell death. DO11.10 or
KMIs-8.3.5 cells expressing full-length or
truncated RORgt or hCD2 were cultured in
2C11-coated plates (125 ng/ml) and tested
for their [3H]Thymidine incorporation. Incor-
poration of cells cultured in medium alone is
calculated as 100%. Numbers indicate the
amino acids contained in each RORgt dele-
tion mutant. An initiation methionine was
added to RORgt deletion mutant 113±495.
(B) FACS analysis of hCD2 expression on
KMIs-8.3.5 cells expressing RORg or RORgt.
Polyclonal KMIs-8.3.5 cell lines expressing
RORg or RORgt were generated by panning
on anti-hCD2 MAb-coated plates, and adher-
ent cells were stained with a FITC-anti-hCD2
as indicated. The profile at the far left repre-
sents parental KMIs-8.3.5 cells stained with
anti-hCD2 MAb.
(C) Comparison of the anti-apopototic effects
by RORg and RORgt. KMIs-8.3.5 cells ex-
pressing RORg (diamonds), RORgt (circles),
or control cells (squares) shown in (B) were
cultured in 2C11-coated plates and tested as
described in (A).
cellular viability measured by either propidium iodide effect against anti-CD3 stimulation in either cell line (Fig-
ure 4A). These results indicate that both DBD and LBDuptake (Figure 3B) or trypan blue exclusion, which re-
are required for RORgt to protect cells from activation-vealed that the viability for DO11.10hCD2 and DO11.10
induced cell death. One caveat to the interpretation ofRORgt are 1%±2% and 85%±95%, respectively, after
these data is that the protein expression levels of these16±24 hr treatment with anti-CD3 MAb.
constructs have not been confirmed due to the lack ofAs shown in Figure 3A, DO11.10 cells expressing RORgt
an antibody to RORgt.were protected from anti-CD3-induced cell death. In
We further examined whether RORg also protects Tcontrast, control cells were readily induced to undergo
cell hybridoma from activation-induced apoptosis. KMIs-apoptosis. This anti-apoptotic effect by RORgt is not
8.3.5 polyclonal cell lines expressing either RORgt ordue to impaired TCR-CD3-mediated stimulation, since
RORg were stimulated with anti-CD3 MAb or PMA plusthese DO11.10RORgt clones express comparable levels
ionomycin. Even though RORg was expressed at a higherof CD3 on their surface relative to control cells (data not
level in the hybridoma cells than RORgt as assessed byshown). Furthermore, DO11.10RORgt clones were also
the cell surface expression of the reporter hCD2 (Figurerefractory to apoptosis induced by PMA plus ionomycin,
4B), the protection against apoptosis mediated by RORgwhich bypass the TCR (Figure 3A). The anti-apoptotic
was much less effective than that by RORgt when theseeffect of RORgt was further tested on another T cell
cells were stimulated with either anti-CD3 (Figure 4C)hybridoma, KMIs-8.3.5 (Park et al., 1996). Similarly to
or PMA plus ionomycin (data not shown). These results,DO11.10RORgt, KMIs-8.3.5RORgt cells were protected
together with their differential expression pattern, sug-from treatment by either anti-CD3 MAb or PMA plus
gest that RORg and RORgt perform distinct functions.ionomycin, whereas control KMIs-8.3.5hCD2 cells suc-
cumbed to cell death with almost no [3H]Thymidine
RORgt Negatively Regulates Fas Liganduptake (Figure 3A). These data indicate that RORgt pro-
Expression and IL-2 Productiontected T cell hybridomas from activation-induced apo-
To explore the mechanism by which RORgt protects Tptosis.
cell hybridomas from activation-induced apoptosis, we
first examined Fas and Fas ligand expression following
Both the DBD and LBD Are Required for RORgt activation. KMIs-8.3.5 cells were stimulated with anti-
to Protect Hybridomas from Activation-Induced CD3 MAb for 4±5 hr and the surface expression of Fas
Cell Death and Fas ligand were determined by FACS analysis. Fas
To map the regions of RORgt that are required for the ligand was strongly induced and Fas was slightly upreg-
anti-apoptotic effect, we made four constructs that con- ulated in control KMIs-8.3.5hCD2 cells. In contrast, Fas
sist of either the DBD or the LBD of RORgt and trans- ligand induction was dramatically inhibited in cells ex-
duced them into both DO11.10 and KMIs-8.3.5 cells pressing RORgt (Figure 5A). The lack of Fas ligand induc-
using the pMI vector (Figure 4A). None of these four tion was not due to insufficient stimulation and/or activa-
tion since the upregulation of the T cell activation markerdeletion mutants of RORgt displayed an anti-apoptotic
A Novel Orphan Receptor Isolated from Thymus
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Figure 5. RORgt Inhibits Activation-Induced
Fas Ligand Upregulation in KMIs-8.3.5 Cells
(A) FACS analysis of cell surface expression
of Fas, Fas ligand, and CD69 in KMIs-
8.3.5hCD2 control or KMIs-8.3.5RORgt cells
after TCR-mediated activation. KMI-8.3.5
cells expressing RORgt and control cells
were activated on 2C11-coated plates for 4.5
hr and the cell surface phenotype was exam-
ined by FACS (filled, before stimulation; un-
filled, after stimulation). A similar pattern was
observed when PMA (10 ng/ml) and iono-
mycin (0.2 mg/ml) were used as stimuli (data
not shown).
(B) Northern blot analysis of RNA expression
of Fas ligand, Nur-77, and Egr-3 in KMIs-
8.3.5hCD2 control, or KMIs-8.3.5RORgt cells
after TCR-mediated activation. Cells were ac-
tivated in 2C11-coated plates (125 ng/ml) for
the indicated time, harvested, and extracted
for total RNA. 15 mg total RNA was used for
each sample. GAPDH serves as a loading
control.
CD69 was not affected by RORgt (Figure 5A). Further- amount of IL-2 was detected from KMIs-8.3.5hCD2 cells
upon TCR stimulation, whereas only very low amountsmore, the upregulation of other surface molecules such
as CD44 and the downregulation of CD62L upon TCR of IL-2 were produced by KMIs-8.3.5RORgt cells (Figure
6). This inhibition of IL-2 production by RORgt could notstimulation were similar in both KMIs-8.3.5hCD2 and
KMIs-8.3.5RORgt cells (data not shown). To determine be overcome by stimulation with PMA plus ionomycin
(data not shown). Taken together, these data demon-at which level RORgt negatively regulates Fas ligand
expression, Northern blot analyses were performed. Fol- strate that RORgt negatively regulates some, but not all,
aspects of the activation program in T cell hybridomas.lowing TCR stimulation, the expression of Fas ligand
mRNA was induced as early as 2 hr and peaked at 4 hr
in control KMIs-8.3.5hCD2 cells. In contrast, the induc- RORgt Does Not Inhibit Fas-Mediated
tion of Fas ligand mRNA was strongly inhibited in KMIs- or Other Forms of Apoptosis
8.3.5RORgt cells, indicating that RORgt regulates Fas To test whether RORgt inhibits T cell apoptosis induced
ligand expression at the transcriptional level (Figure 5B). by Fas signaling, KMIs-8.3.5hCD2 and KMIs-8.3.5RORgt
Previous experiments showed that the orphan nuclear cells were cocultured with L929 or L929FasL cells, and
receptor Nur-77 positively regulates Fas ligand expres-
sion (Weih et al., 1996). To test whether the inhibition
of Fas ligand induction by RORgt is due to an effect on
Nur-77 expression, the same set of RNAs from anti-
CD3-stimulated KMIs-8.3.5hCD2 and KMIs-8.3.5RORgt
were probed with a full-length Nur-77 cDNA. Nur-77 was
induced rapidly and remained strongly positive for 6 hr
in both types of cells (Figure 5B). This result indicates
that RORgt does not negatively regulate Nur-77 tran-
scription. A recent study demonstrated that Egr-3, an
early response gene in cell activation, binds to the Fas
ligand promoter and ectopic expression of Egr-3 acti-
vates Fas ligand expression (Mittelstadt and Ashwell,
1998). Thus, we further evaluated whether expression
of RORgt affects Egr-3 transcription. As shown in Figure
5B, Egr-3 was induced to the same level in KMIs-
Figure 6. Expression of RORgt Inhibits IL-2 Production by T Cell8.3.5RORgt cells as in KMIs-8.3.5hCD2 control cells.
Hybridomas
One hallmark of T cell hybridoma activation is IL-2
KMIs-8.3.5hCD2 control (squares) or KMIs-8.3.5RORgt cells (circles)production. To examine the effect of RORgt on IL-2
were cultured for 20 hr in 96-well plates coated with the indicated
production, cells were stimulated with various concen- amount of 2C11, and the supernatants were tested for IL-2 using a
trations of anti-CD3 MAb for 20 hr and the culture super- HT-2 bioassay. Shown are representative results from three similar
experiments.natant assayed for IL-2. As expected, a significant
Immunity
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Figure 7. Expression of RORgt in T Cell Hy-
bridoma Does Not Prevent Cell Death In-
duced by Fas Signaling or Other Stimuli
(A) RORgt does not inhibit Fas-induced killing
in KMIs-8.3.5 cells. KMIs-8.3.5hCD2 control
or KMIs-8.3.5RORgt cells were cocultured
with L929 or L929FasL cells at a ratio of 1:3.
Two days later, the percentage of hCD2 posi-
tive cells from cells cocultured with L929
(empty column) or L929FasL (filled column)
were determined by FACS.
(B) RORgt does not inhibit cell death induced
by dexamethasone, ceramide, and stauro-
sporine. KMIs-8.3.5hCD2 control or KMIs-
8.3.5RORgt cells were cultured in the pres-
ence of indicated stimuli and [3H]Thymidine
incorporation measured. [3H]Thymidine up-
take of cells cultured in medium alone is cal-
culated as 100%. Shown are results from two
individual KMIs-8.3.5RORgt clones (circles)
and KMIs-8.3.5hCD2 control cells (squares).
cell survival was quantitated by FACS analysis of hCD2 RORgt is a novel isoform of RORg. It shares with RORg
identical nucleotide sequence from exon 3 through thepositive cells. Compared with cells cocultured with L929,
last exon, which contains the conserved DBD and puta-both control and RORgt expressing KMIs-8.3.5 cells suf-
tive LBD (Medvedev et al., 1997). RORg belongs to thefered significant loss when cultured with L929FasL (Fig-
ROR/RZR orphan receptor subfamily of nuclear recep-ure 7A), indicating that expression of RORgt does not
tors. This subfamily consists of RORa (a1, a2, a3), RZRb,interfere with the Fas apoptotic pathway.
and RORg (Carlberg et al., 1994; GigueÁ re et al., 1994;We also tested the effect of RORgt on apoptosis in-
Hirose et al., 1994; Ortiz et al., 1995). RORg shares 51%duced by other stimuli. Glucocorticoids induce immature
and 50% identity at the amino acid level with humanthymocytes as well as T cell lines to undergo apoptosis
RORa and rat RZRb, respectively, with the highest iden-(Zacharchuk et al., 1990; Cohen, 1992). Staurosporine
tity in the DBD (89% and 91%, respectively). The distinctis a broad-spectrum protein kinase inhibitor and induces
59 sequences of RORgt and RORg are likely due to alter-apoptosis among various cell types (Raff et al., 1993).
nate RNA processing of a common transcript, ratherCeramide is implicated in the signaling pathway that
than differential transcription of different genes, sincemediates apoptosis induced by Fas and TNFa (Cifone
Southern blot analysis revealed RORg as a unique geneet al., 1994). As shown in Figure 7B, expression of RORgt
(Ortiz et al., 1995). Interestingly, the three isoforms ofhad no effect on T cell apoptosis induced by any of these
RORa are also generated by alternate RNA splicing (Gi-stimuli. These data demonstrate that RORgt specifically
gueÁ re et al., 1994). Like RORgt and RORg, these isoformsregulates genes that are related to T cell activation.
differ only in the region encoding the N terminus. In the
case of RORgt and RORg, this difference is functionally
Discussion significant (see below).
The function of the widely expressed RORg is not
Nuclear receptors form a superfamily that consists of clear. DNA-binding studies demonstrated that RORg
more than 60 members (Laudet, 1997). The majority of binds specifically to a direct repeat of the half-site se-
nuclear receptors share a common modular structure quence PuGGTCA with a 4 or 5 nucleotide spacer (Ortiz
consisting of four principal domains. The amino-terminal et al., 1995; Medvedev et al., 1996). This core motif also
domain encodes transactivating activity. The central DNA- serves as the binding site for other members of the ROR/
binding domain is the most conserved among members RZR orphan receptor subfamily (GigueÁ re et al., 1994), as
of this superfamily and participates in either DNA± well as thyroid hormone (TR) and retinoic acid receptors
protein or protein±protein interactions. The carboxy-ter- (RAR) (Laudet, 1997), because of the highly conserved
minal ligand-binding domain, which is moderately con- DBD among these receptors. When cotransfected with
served, serves for ligand binding, dimerization, and TR and RAR, RORg is able to repress the transcriptional
transcriptional activation or repression. The hinge do- activities of these receptors on their corresponding re-
main located between the DBD and the LBD is poorly sponse elements (Ortiz et al., 1995). It is likely that RORgt
conserved and, in many cases, harbors nuclear localiza- is also able to bind to the same core sequence. However,
tion signals (Beato et al., 1995; Mangelsdorf and Evans, the different efficiency of the repression of T cell hybrid-
oma apoptosis by RORgt and RORg suggests that these1995; Laudet, 1997).
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two isoforms may have different specificity for target in thymocytes of Nur-77 transgenic mice results in a
genes, and the specificity is determined by the distinct dramatic reduction of DP as well as SP thymocytes
N terminus in these two isoforms. In support of this, the due to the early onset of apoptosis. Furthermore, this
three isoforms of RORa (a1, 2, and 3) showed distinct massive cell death could be partially rescued in a gld
DNA-binding specificity (GigueÁ re et al., 1994). mouse background that contains a mutation in Fas li-
The mechanism by which RORgt negatively regulates gand (Weih et al., 1996).
Fas ligand expression and IL-2 production remains elu- The capacity of the different thymocyte subsets to
sive. It may directly bind to the promoters for Fas ligand produce IL-2 is developmentally regulated, and we sug-
and IL-2 and repress their transcriptional activity. Alter- gest that it may be controlled by RORgt. DP thymocytes
natively, RORgt may indirectly regulate genes that are express a high level of RORgt and do not produce IL-2
involved in the expression of these two genes by transcrip- upon stimulation (Fischer et al., 1991). When DP thymo-
tional control or protein interaction. Several genes in- cytes mature into the SP stage, they gain the capacity
cluding Nur-77 (Weih et al., 1996), Egr-3 (Mittelstadt and to make IL-2 (Fischer et al., 1991). Correlating with this,
Ashwell, 1998), ALG-3 (Vito et al., 1996), GILZ (D'Adamio SP thymocytes and splenic T cells do not express
et al., 1997), NF-AT (Latinis et al., 1997), RAR, and GR RORgt. DN thymocytes, which contain the precursor for
(Yang et al., 1995) have been shown to regulate Fas DP thymocytes, are extremely heterogeneous in terms
ligand expression in vitro and in vivo. To date, the mech- of their surface phenotype as defined by CD44 and CD25
anisms by which these gene products control Fas ligand (Godfrey et al., 1993) and in terms of their ability to
expression and how they interact with each other are produce IL-2 (Zlotnik et al., 1992). The most mature,
not well understood. The rapid induction of Nur-77 CD442CD252 subpopulation of DN thymocytes, which
mRNA was not changed in KMIs-8.3.5RORgt cells, and gives rise directly to DPs, are unable to produce IL-2,
it remains to be determined whether RORgt affects Nur- while the earlier subpopulations defined by these sur-
77 function by inhibiting its DNA binding capacity to the face markers have the ability to make IL-2 (Zlotnik et al.,
same core motif PuGGTCA (Wilson et al., 1991) or by 1992). Our RT-PCR data revealed a low level of RORgt
forming a heterodimer with Nur-77, since cross-talk expression in the DN subset, and it would be of interest
among orphan nuclear receptors does occur (Forman in the future to determine whether this expression oc-
et al., 1994). It has been shown that retinoic acid and curs solely in the CD442CD252 subset. This tightly con-
glucocorticoids antagonize TCR-induced apoptosis of trolled ability by immature DP thymocytes to produce
T cell hybridomas by inhibiting Fas ligand upregulation
cytokine has been proposed to be a fail-safe mechanism
(Yang et al., 1995). However, this effect is not mediated
that developing T cells go through before positive and
through RORgt since neither retinoic acid nor glucocorti-
negative selection (Fischer et al., 1991). Thus, any DPcoids induced RORgt expression in DO11.10 or KMIs-
would not have effector function until the selection has8.3.5 hybridoma cells (He and Bevan, unpublished data).
been completed. The molecular mechanism for this phe-One potential role of RORgt in thymocyte develop-
nomenon is not well understood. Several studies providement is related to its ability to inhibit Fas ligand upregu-
evidence suggesting that the inability to produce IL-2lation. Recent evidence suggests that Fas/Fas ligand
by DP thymocytes is due to the lack of inducibility ofsignaling participates in thymocyte negative selection
two transcription factors, NF-AT and AP-1 (Chen and(Kishimoto et al., 1998). In both normal and transgenic
Rothenberg, 1993; RincoÂ n and Flavell, 1996). The ex-mice, the deletion of a semimature thymocyte popula-
pression pattern of RORgt together with its inhibition ontion, HSAhiCD4182 cells, was shown to be dependent
IL-2 production in T cell hybridomas strongly suggeston Fas when high doses of antigen were applied. The
that one role of RORgt in DP thymocytes is to preventdeletion occurs in the thymic medulla, indicating Fas/
IL-2 production. The relations between RORgt and AP-1Fas ligand-mediated thymocyte negative selection oc-
or members of the NF-AT family remain to be deter-curs at a relatively late stage of thymocyte differentiation
mined.(Kishimoto et al., 1998). This result is consistent with
the expression pattern of both Fas and Fas ligand in the
thymus. Although Fas is highly expressed in cortical Experimental Procedures
immature DP thymocytes as well as CD41 or CD81 SP
Cell Linesthymocytes (Drappa et al., 1993; Andjelic et al., 1994;
DO11.10 (White et al., 1983) and KMIs-8.3.5 (Park et al., 1996) areNishimura et al., 1995; Ogasawara et al., 1995), Fas li-
T cell hybridomas. Subclones of DO11.10 cells were tested for theirgand is primarily expressed in thymic epithelial and den-
survival rate during culture in PMA plus ionomycin. A subclone of
dritic cells located within the medulla (French et al., DO11.10 with a low survival rate under these conditions was se-
1997). Notably, among the three thymocyte subpopula- lected for subsequent expression cloning. FNX-Ampho is a retrovi-
tions that highly express Fas, only immature DP are rus packaging cell line (Hitoshi et al., 1998). L929FasL cells were
derived by transduction of mFas ligand cDNA using the pMX vector,exquisitely sensitive to Fas-induced killing (Nishimura
followed by FACS sorting for Fas ligand expression. Cells wereet al., 1995; Ogasawara et al., 1995). Accordingly, any
cultured in DMEM containing 10% fetal calf serum, 2 mM glutamine,expression of Fas ligand in this thymocyte subset would
25 mM HEPES, 50 mM b-mercaptoethanol, 100 U/ml penicillin, andcause massive cell death before they are subjected to
100 mg/ml streptomycin.
positive or negative selection. Given the primary expres-
sion of RORgt in immature DP thymocytes and its ability
MAbs and Reagents
to inhibit Fas ligand upregulation in T cell hybridomas, Anti-human CD2 MAb, 35.1 (American Type Culture Collection,
we propose that one role of RORgt in the thymus is to Rockville, MD) was purified and labeled in our laboratory. The follow-
repress Fas ligand expression at the DP stage. In sup- ing MAbs were purchased from PharMingen (San Diego, CA): puri-
fied anti-CD3 (145±2C11), PE-anti-Fas (Jo2), PE-anti-CD69 (H1.2F3),port of this view, increased expression of Fas ligand
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and Biotin-anti-FasL (Kay-10). Dexamethasone was purchased from on 1 3 104 cells on a FACScan flow cytometer (Becton Dickinson)
using CellQuest software.Sigma (St. Louis, MO) and ceramide and staurosporine from Calbio-
chem (La Jolla, CA).
Induction of Apoptosis and Thymidine Incorparation Assay
Expression Cloning
Twenty-four or 96-well tissue culture plates were precoated with
A thymocyte cDNA library in the retrovirus vector pMX (Deftos et
rabbit anti-hamster anti-serum (50 mg/ml) overnight at 378C, washed
al., 1998 [this issue of Immunity]) was transfected into FNX-Ampho
with HBSS, and coated with anti-CD3 MAb (145±2C11) at the amount
packaging cell line using CaPO4 precipitation, and retrovirus-con- indicated in the text. Hybridoma cells were added to the plates for
taining supernatant was harvested 2 days after the transfection.
the indicated time, harvested, and analyzed. Alternatively, PMA plus
DO11.10 cells were infected by centrifugation at 2500 rpm for 1.5
ionomycin was added to the culture instead of anti-CD3 MAb. For
hr at 328C with the retrovirus supernatant followed by incubation at
the thymidine incorporation assay, 2 3 104 cells per well were added
328C overnight (Hitoshi et al., 1998). A total of 5 3 106 DO11.10
to 96-well plates, cultured for 20 hr, and labeled with [3H]Thymidine
cells were infected as assessed using control pMX-hCD2 retrovirus
(1 mCi/well, 25 Ci/mmol) (NEN) for a further 4 hr. The cells were
infection. Two days after the infection, DO11.10 cells were placed
harvested on glass-fiber filters and counted in a b scintillation
into 96-well plates (5 3 104 cells/well) and selected for survival and
counter. Data were derived from the mean value of duplicate cul-
growth in the presence of PMA (10 ng/ml) plus ionomycin (0.2 mg/
tures.
ml). Resistant clones were identified after 2±4 weeks in culture.
cDNA inserts were amplified by using RT-PCR with vector-specific
primers that flank the polycloning site of pMX. PCR products were IL-2 Bioassay
sequenced with nested vector-specific primers on an ABI auto- IL-2 was measured using HT-2 cells (Roehm et al., 1983). In brief,
mated sequencer. supernatants from stimulated T cell hybridomas were serially di-
luted, and HT-2 cells were added (4 3 103/well, 96-well plate). Cells
were then cultured for 20 hr and [3H]Thymidine added for a furtherPlasmid Construction and Generation of Transgene
4 hr. [3H]Thymidine incorporation was plotted against supernatantPositive Cell Lines
dilutions. One unit of IL-2 was defined as the dilution of supernatantThe pMI vector was constructed by cloning the internal ribosome
that supports half-maximal proliferation of HT-2 cells, and the totalentry site (IRES) from encephalomyocarditis virus and a cDNA en-
units of IL-2 were extrapolated from the resulting curve.coding the extracellular and transmembrane domains of hCD2 into
the pMX retrovirus vector (Onishi et al., 1996). The resulting vector
contains a polycloning site upstream of an IRES-hCD2 cassette.
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